BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 205903)

  • 1. Nasopharyngeal carcinoma.
    Andersson-Anvret M; Forsby N; Klein G
    Prog Exp Tumor Res; 1978; 21():100-16. PubMed ID: 205903
    [No Abstract]   [Full Text] [Related]  

  • 2. [Rhinopharyngeal carcinoma and Epstein-Barr virus: study of a sample of Italian patients].
    Caliceti U; Cevenini R; Donati M
    Acta Otorhinolaryngol Ital; 1985; 5(1):83-90. PubMed ID: 2994355
    [No Abstract]   [Full Text] [Related]  

  • 3. Epstein-Barr virus-related serology in nasopharyngeal carcinoma and controls.
    Henle W; Henle G; Ho JH
    IARC Sci Publ (1971); 1978; (20):427-37. PubMed ID: 215525
    [No Abstract]   [Full Text] [Related]  

  • 4. Serum IgA antibodies of Epstein-Barr virus (EBV)-related antigens. A new feature of nasopharyngeal carcinoma.
    Henle G; Henle W
    Bibl Haematol; 1975 Oct; (43):322-5. PubMed ID: 183692
    [No Abstract]   [Full Text] [Related]  

  • 5. IgA antibodies to Epstein-Barr viral capsid antigens in saliva of nasopharyngeal carcinoma patients.
    Ho HC; Ng MH; Kwan HC
    Br J Cancer; 1977 Jun; 35(6):888-90. PubMed ID: 194619
    [No Abstract]   [Full Text] [Related]  

  • 6. Nasopharyngeal carcinoma: recent studies and outlook for a viral etiology.
    De-Thé G; Geser A
    Cancer Res; 1974 May; 34(5):1196-206. PubMed ID: 4366989
    [No Abstract]   [Full Text] [Related]  

  • 7. Serological markers in the diagnosis of histopathological types of nasopharyngeal carcinoma.
    Sam CK; Prasad U; Pathmanathan R
    Eur J Surg Oncol; 1989 Aug; 15(4):357-60. PubMed ID: 2547665
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Lymphoepithelial carcinoma of the nasopharynx: a special tumor?].
    Meister P; Nathrath W; Wilmes E; Wolf H
    Verh Dtsch Ges Pathol; 1981; 65():171-5. PubMed ID: 6289547
    [No Abstract]   [Full Text] [Related]  

  • 9. [Study on the relationship between the serum IgA antibody titres to EB VCA and the pathological changes in untreated nasopharyngeal carcinoma (NPC) patients].
    Li JT; Zong YS
    Zhonghua Bing Li Xue Za Zhi; 1986 Jun; 15(2):122-5. PubMed ID: 3022953
    [No Abstract]   [Full Text] [Related]  

  • 10. [Nasopharyngeal carcinoma and the Epstein-Barr virus].
    Boger-Goren S; Gotlieb-Stematsky T
    Harefuah; 1985 May; 108(10):514-6. PubMed ID: 2995214
    [No Abstract]   [Full Text] [Related]  

  • 11. [Humoral response to Epstein-Barr virus of patients with nasopharyngeal cancer and its use in the differential diagnosis of the disease].
    Gurtsevich VE; Plakhov IV; Chuĭkina NA; Abdulin NA
    Vestn Akad Med Nauk SSSR; 1984; (5):29-34. PubMed ID: 6331022
    [No Abstract]   [Full Text] [Related]  

  • 12. [The nasopharyngeal carcinoma and Epstein-Barr virus (EBV) specific IgA (author's transl)].
    Desgranges C
    Pathol Biol (Paris); 1981 Dec; 29(10):587-9. PubMed ID: 6280123
    [No Abstract]   [Full Text] [Related]  

  • 13. Nasopharyngeal carcinoma due to Epstein-Barr virus: serologic tests.
    Smith TF
    Mayo Clin Proc; 1985 Mar; 60(3):205-6. PubMed ID: 2983152
    [No Abstract]   [Full Text] [Related]  

  • 14. Independent effect of EBV and cigarette smoking on nasopharyngeal carcinoma: a 20-year follow-up study on 9,622 males without family history in Taiwan.
    Hsu WL; Chen JY; Chien YC; Liu MY; You SL; Hsu MM; Yang CS; Chen CJ
    Cancer Epidemiol Biomarkers Prev; 2009 Apr; 18(4):1218-26. PubMed ID: 19336547
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A specific histological marker of undifferentiated carcinoma of the nasopharynx. The ACIF (Anti-Complement Immunofluorescence) test].
    Micheau C; De The G; Schwaab G; Tursz T; Sancho-Garnier H; Montagu B
    Ann Pathol; 1984; 4(2):143-6. PubMed ID: 6329239
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A summing-up.
    Klein G
    IARC Sci Publ (1971); 1975; (11 Pt 2):365-97. PubMed ID: 191380
    [No Abstract]   [Full Text] [Related]  

  • 17. Animal models for nasopharyngeal carcinoma.
    Ablashi DV; Easton JM; Glaser R
    IARC Sci Publ (1971); 1978; (20):85-94. PubMed ID: 215536
    [No Abstract]   [Full Text] [Related]  

  • 18. [Relation between the growth pattern and the quantity of plasma cells of nasopharyngeal cancer (NPC) and serum EBV antibody level].
    Li JT
    Zhonghua Zhong Liu Za Zhi; 1985 Jan; 7(1):9-11. PubMed ID: 2983963
    [No Abstract]   [Full Text] [Related]  

  • 19. [Mucoepidermoid carcinoma of nasopharynx: a report of twelve cases].
    Qiu F; Hua YJ; Guo L; He JH; Qiu XL; Hong MH
    Ai Zheng; 2005 Mar; 24(3):362-4. PubMed ID: 15757543
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [IgG and IgA antibodies to the Epstein-Barr virus and nasopharyngeal carcinoma].
    Vera Sempere FJ
    Med Clin (Barc); 1992 May; 98(19):758-9. PubMed ID: 1318986
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.